Sarcomatrix
Early Stage
Building Strength, Building Futures
Overview
Raised: $25,365
Total Commitments ($USD)
Platform
StartEngine
Start Date
04/30/2024
Close Date
07/29/2024
Min. Goal
$15,000
Max. Goal
$1,235,000
Min. Investment
$500
Security Type
Equity - Common
SEC Filing Type
RegCF
Price Per Share
$2.50
Pre-Money Valuation
$14,250,000
Rolling Commitments ($USD)
Status
Active
Reporting Date
05/15/2024
Days Remaining
74
% of Min. Goal
169%
% of Max. Goal
2%
Likelihood of Max
Avg. Daily Raise
$1,691
# of Investors
14
Momentum
Create a free account today to gain access to KingsCrowd analytics.
Year Founded
2022
Industry
Healthcare & Pharmaceuticals
Tech Sector
HealthTech
Location
Reno, Nevada
Sarcomatrix, with a valuation of $14.25 million, is raising funds on StartEngine. The company is developing assets for the treatment of muscle diseases using innovative techniques. Sarcomatrix is in the pre-revenue and pre-commercialization stages of development, with two major assets nearing first-in-human clinical trials. The company aims to target the root causes of neuromuscular disorders rather than only addressing the symptoms and has received NIH grants for its research. David Craig founded Sarcomatrix in May 2022. The current crowdfunding campaign has a minimum target of $15,000 and a maximum target of $1.24 million. The campaign proceeds will be used for research and development, inventory, company employment, and working capital.
Summary Profit and Loss Statement
| FY 2023 | FY 2022 | |
|---|---|---|
|
Revenue |
$0 |
$0 |
|
COGS |
$0 |
$0 |
|
Tax |
$0 |
$0 |
| ||
| ||
|
Net Income |
$-103,375 |
$0 |
Summary Balance Sheet
| FY 2023 | FY 2022 | |
|---|---|---|
|
Cash |
$36,803 |
$0 |
|
Accounts Receivable |
$0 |
$0 |
|
Total Assets |
$36,803 |
$0 |
|
Short-Term Debt |
$18,894 |
$0 |
|
Long-Term Debt |
$113,330 |
$0 |
|
Total Liabilities |
$132,224 |
$0 |
Financials as of: 04/30/2024
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.